Report Categories Report Categories

Report Categories

industry Category

All

Total: 5 records, 1 pages

Global Multiple Sclerosis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

According to our (Global Info Research) latest study, the global Multiple Sclerosis Therapeutics market size was valued at USD 17530 million in 2023 and is forecast to a readjusted size of USD 20010 million by 2030 with a CAGR of 1.9% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Multiple Sclerosis Therapeutics Supply, Demand and Key Producers, 2023-2029

date 11 Feb 2023

date Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

USD4480.00

Add To Cart

Add To Cart

Global Multiple Sclerosis Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

USD3480.00

Add To Cart

Add To Cart

Global Multiple Sclerosis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

new_biaoQian multiple sclerosis therapeutics

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

Add To Cart

Global Multiple Sclerosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 02 Jul 2021

date Pharma & Healthcare

new_biaoQian multiple sclerosis therapeutics

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

According to our (Global Info Research) latest study, the global Multiple Sclerosis Therapeutics market size was valued at USD 17530 million in 2023 and is forecast to a readjusted size of USD 20010 million by 2030 with a CAGR of 1.9% during review period.

USD3480.00

addToCart

Add To Cart

industry 11 Feb 2023

industry Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

USD4480.00

addToCart

Add To Cart

industry 07 Jan 2023

industry Pharma & Healthcare

new_biaoQian Multiple Sclerosis Therapeutics

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

USD3480.00

addToCart

Add To Cart

industry 08 Jan 2022

industry Pharma & Healthcare

new_biaoQian multiple sclerosis therapeutics

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

addToCart

Add To Cart

industry 02 Jul 2021

industry Pharma & Healthcare

new_biaoQian multiple sclerosis therapeutics

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

addToCart

Add To Cart